Preparation method of polypeptide capable of promoting bone cell growth

Through gene cloning and expression vector optimization, cell suspension culture and multi-step purification technology, the problems of low expression efficiency and complex purification in PTHrP preparation were solved, and high yield and high purity PTHrP preparation was achieved, which promoted its biomedical research and Wide application of clinical applications.

CN118909081AInactive Publication Date: 2024-11-08HAINAN YANTI TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410898997.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-05
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing PTHrP preparation methods rely on bioengineering technology, resulting in low expression efficiency, complex isolation and purification, affecting yield and quality, limiting its widespread use in biomedical research and clinical applications.

Method used

Through gene cloning, construction of expression vectors, transforming host cells, cell suspension culture, isolation and purification, the expression and purification process of PTHrP is optimized, and PCR amplification, affinity chromatography, and ion exchange chromatography are used to improve the Expression level and purity.

Benefits of technology

It improves the yield and purity of PTHrP and obtains higher bioactive products, supporting its wide application in biomedical research and clinical applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909081A_ABST
    Figure CN118909081A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of a polypeptide capable of promoting bone cell growth, and relates to the technical field of biological medicines, and the preparation method comprises the following steps: S1, gene cloning; s2, constructing an expression vector; s3, transforming host cells; s4, culturing and expressing; s5, separation and purification; and S6, quality detection. According to the preparation method of the polypeptide capable of promoting the growth of the bone cells, an expression system is optimized by adjusting the design of an expression vector, selecting host cells and optimizing culture conditions, so that the expression level of PTHrP is improved, different types of host cells are specifically cultured by adopting a cell suspension culture technology so as to improve the yield and purity of PTHrP, and in addition, the preparation method of the polypeptide capable of promoting the growth of the bone cells has good application prospects. According to the present invention, the PTHrP with characteristics of high yield, high purity and stable biological activity is obtained by combining the affinity chromatography and the ion exchange chromatography to perform multi-step purification, such that the purification efficiency and the purity are further improved so as to provide the powerful support for the wide application of the PTHrP in the biomedical research and the clinical application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedicine technology, and in particular to a method for preparing a polypeptide capable of promoting bone cell growth. Background Art

[0002] Peptides are compounds composed of multiple amino acids linked by peptide bonds, and their molecular structure is between amino acids and proteins. Since the beginning of the 20th century, with the advancement of biochemistry, scientists have begun to study amino acids, the basic units that make up proteins, and discovered peptides in the process of exploring how amino acids combine to form proteins.

[0003] In terms of peptide synthesis, Merrifield first proposed the solid-phase peptide synthesis method in 1963, which triggered a revolution in the field of peptide organic synthesis. Subsequently, this technology gradually developed into an independent discipline, greatly promoting the automation of peptide synthesis. In the early 1980s, the emergence of the world's first peptide synthesizer marked the beginning of a new era in peptide synthesis. Scientists can synthesize peptides more conveniently, thereby conducting more biomedical research. In recent years, with the continuous advancement of technology, many emerging technologies have emerged in the field of peptides, such as multifunctional peptides, constrained peptides, oral peptides, and long-acting delivery systems. The development of these technologies has greatly promoted the development of the field of peptide drugs, making the application of peptides in drug research and development, disease treatment and other fields more extensive and in-depth.

[0004] Parathyroid hormone-related protein, also known as parathyroid hormone-related peptide, referred to as PTHrP, is a type of polypeptide that was originally isolated from malignant tumor tissue associated with hypercalcemia. Through in-depth research, researchers have found that parathyroid hormone-related protein can promote bone cell growth, revealing its important role in calcium and phosphorus metabolism, bone development, etc., and providing new ideas and methods for the diagnosis and treatment of related diseases.

[0005] However, the prior art still has the following defects when preparing parathyroid hormone-related protein:

[0006] Existing methods for preparing PTHrP mainly rely on bioengineering technology, especially recombinant DNA technology. However, since the expression efficiency of PTHrP in some host cells may not be high, resulting in low yield, and PTHrP may be closely bound to other cell components, the separation and purification steps are complicated and time-consuming, affecting the production efficiency and quality of PTHrP, which is not conducive to its mass production, and thus is not conducive to the widespread application of PTHrP in biomedical research and clinical applications.

[0007] Therefore, it is urgent to improve this shortcoming. The present invention studies and improves the existing structure and shortcomings, and provides a method for preparing a polypeptide that can promote bone cell growth. Summary of the invention

[0008] The purpose of the present invention is to provide a method for preparing a polypeptide that can promote bone cell growth, so as to solve the problems raised in the above background technology.

[0009] To achieve the above object, the present invention provides the following technical solution: a method for preparing a polypeptide capable of promoting bone cell growth, comprising the following steps:

[0010] S1. Gene cloning: Obtain the gene sequence of PTHrP from the human genome or cDNA library, then amplify the PTHrP gene sequence by PCR, and sequence the amplified product to verify it. Compare the sequencing result with the original gene sequence to ensure that no errors or mutations are introduced;

[0011] S2. Construction of expression vector: Considering the target host cell, the regulation mode of gene expression, the stability and capacity of the vector, plasmid, virus or yeast expression is selected as the expression vector, and the amplified PTHrP gene sequence is inserted into the expression vector;

[0012] S3. Transformation of host cells: Select the most suitable host cell type according to the expression requirements of PTHrP, and transfer the constructed expression vector into the host cells to make the cells express PTHrP;

[0013] S4. Culture and expression: host cells were cultured using cell suspension culture technology to promote the expression of PTHrP. During the culture process, aseptic operation specifications were strictly followed, and the cell density and growth status were regularly monitored. At the same time, fresh culture medium was replaced in a timely manner according to the cell growth and culture medium consumption;

[0014] S5. Isolation and purification: Select chromatography columns and reagents with high resolution and stability, and use affinity chromatography and ion exchange chromatography in combination for multi-step purification to isolate and purify PTHrP from cell culture;

[0015] S6. Quality testing: The purity, activity and structure of PTHrP are identified through biological activity testing and mass spectrometry analysis.

[0016] Furthermore, in step S1, the specific steps of PCR amplification are as follows:

[0017] Primer design: Based on the known PTHrP gene sequence, a pair of specific primers are designed, and the primers are located at both ends of the target sequence to guide DNA synthesis during PCR;

[0018] Template DNA preparation: Prepare template DNA according to the obtained gene sequence;

[0019] PCR reaction system establishment: Establish a reaction system in a PCR tube, including template DNA, primers, dNTPs, PCR buffer and Taq enzyme. These components together constitute a complete PCR reaction system;

[0020] Thermal cycling: Place the PCR reaction system in a PCR instrument and perform thermal cycling;

[0021] Product analysis: After the PCR reaction is completed, the PCR product is analyzed by agarose gel electrophoresis. The bands on the electrophoresis pattern are observed to determine whether the PCR amplification is successful and to preliminarily judge the quality and size of the product.

[0022] Furthermore, the thermal cycle includes three steps of denaturation, annealing and extension, and these three steps are repeated 25 to 40 times. The specific operations of denaturation, annealing and extension are as follows:

[0023] Denaturation: Under high temperature conditions of 94-98°C, the double-stranded template DNA is dissociated into single strands;

[0024] Annealing: Lower the temperature to 50-65°C to allow the primer to bind to a specific site on the single strand of template DNA;

[0025] Extension: Under high temperature conditions of 72°C, DNA polymerase extends along the primer to synthesize a new DNA chain.

[0026] Furthermore, in step S2, when designing the expression vector, the PTHrP gene sequence is codon optimized according to the codon preference of the target host cell to improve the expression efficiency of the gene in the specific host cell, and ensure that the vector contains elements that stabilize the mRNA structure, such as the untranslated region and the optimized poly (A) tail, to improve the stability and translation efficiency of the mRNA.

[0027] Furthermore, in step S3, the correspondence between the host cell type and the expression requirement of PTHrP is as follows:

[0028] Escherichia coli: lacks the post-translational modification mechanisms unique to eukaryotic cells, such as glycosylation and phosphorylation, and is suitable for expressing PTHrP fragments or smaller proteins with simple structures that do not require complex post-translational modifications;

[0029] Yeast cells: used to perform some post-translational modifications of eukaryotic cells, such as glycosylation. They are relatively low-cost, but cannot fully simulate the complex modification process of mammalian cells. They are suitable for expressing PTHrP with moderate complexity, especially proteins that require a certain degree of post-translational modification.

[0030] Mammalian cells: used to provide post-translational modifications that are closest to the human environment, including glycosylation, phosphorylation, disulfide bond formation, etc., to ensure the correct folding and activity of PTHrP, but with high culture costs, slow growth rates, and relatively complex operations. They are suitable for expressing PTHrP with complex structures and requiring highly specific post-translational modifications;

[0031] Insect cells: Suitable for PTHrPs that are poorly expressed in E. coli but do not require the complex modifications of mammalian cells.

[0032] Furthermore, in step S4, the culture process of the cell suspension culture technology for different types of host cells is as follows:

[0033] Type 1: Suspension culture of Escherichia coli

[0034] Prepare the culture medium: Select LB medium as the culture medium for the growth of E. coli and perform sterilization;

[0035] Inoculation: Inoculate E. coli into the culture medium, making sure the inoculum volume is appropriate;

[0036] Shake flask culture: Place the inoculated culture medium into a shaker, set the appropriate temperature and speed, and perform suspension culture;

[0037] Observation and recording: Regularly observe the growth of E. coli and record the growth curve and colony morphology;

[0038] Collection and preservation: When E. coli grows to a suitable density, it is collected and preserved as needed;

[0039] Type 2: Suspension culture of yeast cells

[0040] Prepare the culture medium: Select YPD medium as the culture medium for yeast cell growth and perform sterile treatment;

[0041] Inoculation: Inoculate the yeast cells into the culture medium, making sure the inoculum volume is appropriate;

[0042] Shake flask or bioreactor culture: Place the inoculated culture medium in a shaker or bioreactor for suspension culture, and strictly control the temperature, pH value and ventilation volume;

[0043] Observation and recording: Regularly observe the growth and morphological changes of yeast cells and record relevant data;

[0044] Collection and utilization: Collect yeast cell supernatant or cell precipitate according to experimental requirements for subsequent experiments or production;

[0045] Type 3: Suspension culture of mammalian cells

[0046] Prepare the culture medium: Select serum-free medium as the culture medium for mammalian cell growth and perform sterilization;

[0047] Inoculation: Inoculate mammalian cells into culture medium at a density determined by cell type and experimental requirements;

[0048] Bioreactor culture: Use bioreactors for suspension culture, control parameters such as temperature, pH and stirring speed to ensure that cells are evenly suspended and fully exposed to the culture medium;

[0049] Observation and recording: Regularly observe the growth and morphological changes of cells and record relevant data;

[0050] Passaging and collection: When the cell density reaches a certain level, cell passage is performed and cell supernatant or cell pellet is collected as needed;

[0051] Type 4: Suspension culture of insect cells

[0052] Prepare the culture medium: Select SF900 medium as the culture medium for insect cell growth and perform sterile treatment;

[0053] Inoculation: Inoculate insect cells into the culture medium at a moderate density;

[0054] Shake flask or bioreactor culture: Place the inoculated culture medium in a shaker or bioreactor for suspension culture, and strictly control the temperature, pH value and ventilation volume;

[0055] Observation and recording: Regularly observe the growth and morphological changes of insect cells and record relevant data;

[0056] Collection and utilization: Collect insect cell supernatant or cell precipitate according to experimental requirements for subsequent experiments or production.

[0057] Furthermore, in step S4, the culture temperature is maintained within the optimal range for host cell growth according to the type of host cells, and the pH value of the culture medium is adjusted using a buffer such as sodium bicarbonate and HEPES to ensure that the pH value is stable within the range required for cell growth. At the same time, it is ensured that there is sufficient oxygen and carbon dioxide concentration in the incubator to support the metabolic activity of the cells, and the culture conditions for different types of host cells are as follows:

[0058] Escherichia coli: The culture temperature is controlled at 32-37°C and the pH value is controlled at 7.0-7.5;

[0059] Yeast cells: The culture temperature is controlled at 25-30°C and the pH value is controlled at 4.5-5.0;

[0060] Mammalian cells: The culture temperature is controlled at 36.5±0.5℃ and the pH value is controlled at 7.4;

[0061] Insect cells: The culture temperature was controlled at 28°C and the pH value was controlled in the range of 6.0 to 6.4.

[0062] Furthermore, in step S4, the operation of PTHrP expression is as follows:

[0063] Gene transfection: Transfect the vector containing the PTHrP gene into the host cell so that it is integrated into the cell genome and expressed;

[0064] Induced expression: Use inducers, such as hormones, chemicals, etc., to stimulate host cells to express PTHrP.

[0065] Furthermore, in step S5, the operation process of affinity chromatography is as follows:

[0066] Ligand selection: Select a ligand with specific affinity to PTHrP, such as an antibody to PTHrP or its specific binding protein, to recognize and bind to PTHrP and separate it from other impurities;

[0067] Immobilized ligand: The selected ligand is immobilized on the insoluble matrix of the affinity chromatography column, such as agarose beads, by covalent bonding;

[0068] Sample processing: centrifuging and filtering the cell culture to remove cell debris and other impurities to obtain a crude extract containing PTHrP;

[0069] Affinity chromatography separation: The crude extract is passed through an affinity chromatography column, where PTHrP will bind to the ligand fixed on the matrix, while other impurities will flow out with the eluent;

[0070] Elution and collection: By changing the composition or conditions of the eluent, such as pH value, ionic strength, etc., PTHrP is dissociated from the ligand, and the eluent is collected, which contains high-purity PTHrP.

[0071] Furthermore, in step S5, the operation process of ion exchange chromatography is as follows:

[0072] Selection of ion exchangers: Based on the charge properties of PTHrP, select cation or anion exchangers with charges opposite to those of PTHrP;

[0073] Sample loading: Load the preliminarily treated solution containing PTHrP onto the ion exchange chromatography column;

[0074] Elution and separation: PTHrP is gradually dissociated from the ion exchanger by gradually increasing the salt concentration of the eluent or changing the pH value. The dissociation rates of PTHrP and other impurities will be different under different conditions to achieve separation.

[0075] Collection and purification: Collect the eluate containing PTHrP and perform necessary subsequent treatments, such as concentration and desalting, to further improve purity and yield.

[0076] The present invention provides a method for preparing a polypeptide that can promote bone cell growth, which has the following beneficial effects:

[0077] The present invention optimizes the expression system by adjusting the design of the expression vector, the selection of the host cells and the optimization of the culture conditions, thereby improving the expression level of PTHrP, and adopts the cell suspension culture technology to culture different types of host cells in a targeted manner to improve the yield and purity of PTHrP. In addition, affinity chromatography and ion exchange chromatography are combined to perform multi-step purification to further improve the purification efficiency and purity. The improved polypeptide preparation method can obtain PTHrP with higher yield, higher purity and more stable biological activity, thereby providing strong support for its wide application in biomedical research and clinical applications. BRIEF DESCRIPTION OF THE DRAWINGS

[0078] Figure 1 This is a schematic diagram of the operation process of a method for preparing a polypeptide capable of promoting bone cell growth according to the present invention;

[0079] Figure 2 The present invention is a PCR amplification flow chart of a method for preparing a polypeptide capable of promoting bone cell growth. DETAILED DESCRIPTION

[0080] The following embodiments of the present invention are described in further detail in conjunction with the accompanying drawings and examples. The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.

[0081] like Figure 1-Figure 2 As shown, a method for preparing a polypeptide capable of promoting bone cell growth comprises the following steps:

[0082] S1. Gene cloning: Obtain the gene sequence of PTHrP from the human genome or cDNA library, then amplify the PTHrP gene sequence by PCR, and sequence the amplified product to verify it. By comparing the sequencing result with the original gene sequence, ensure that no errors or mutations are introduced; the specific steps of PCR amplification are as follows:

[0083] Primer design: Based on the known PTHrP gene sequence, a pair of specific primers are designed, and the primers are located at both ends of the target sequence to guide DNA synthesis during PCR;

[0084] Template DNA preparation: Prepare template DNA according to the obtained gene sequence;

[0085] PCR reaction system establishment: Establish a reaction system in a PCR tube, including template DNA, primers, dNTPs, PCR buffer and Taq enzyme. These components together constitute a complete PCR reaction system;

[0086] Thermal cycling: Place the PCR reaction system in a PCR instrument and perform thermal cycling; thermal cycling includes three steps: denaturation, annealing, and extension, and these three steps are repeated 25 to 40 times. The specific operations of denaturation, annealing, and extension are as follows: Denaturation: Under high temperature conditions of 94 to 98°C, the double-stranded template DNA is dissociated into single strands; Annealing: Lower the temperature to 50 to 65°C to allow the primer to bind to a specific site of the single-stranded template DNA; Extension: Under high temperature conditions of 72°C, DNA polymerase extends along the primer to synthesize a new DNA chain;

[0087] Product analysis: After the PCR reaction is completed, the PCR product is analyzed by agarose gel electrophoresis. The bands on the electrophoresis pattern are observed to determine whether the PCR amplification is successful and to preliminarily judge the quality and size of the product.

[0088] S2. Constructing an expression vector: Considering the target host cell, the regulation mode of gene expression, the stability and capacity of the vector, plasmid, virus or yeast expression is selected as the expression vector, and the amplified PTHrP gene sequence is inserted into the expression vector; when designing the expression vector, the PTHrP gene sequence is codon optimized according to the codon preference of the target host cell to improve the expression efficiency of the gene in the specific host cell, and ensure that the vector contains elements that stabilize the mRNA structure, such as the untranslated region and the optimized poly (A) tail, to improve the stability and translation efficiency of the mRNA;

[0089] S3. Transformation of host cells: Select the most suitable host cell type according to the expression requirements of PTHrP, and transfer the constructed expression vector into the host cell to make the cell express PTHrP; the correspondence between the host cell type and the expression requirements of PTHrP is as follows:

[0090] Escherichia coli: lacks the post-translational modification mechanisms unique to eukaryotic cells, such as glycosylation and phosphorylation, and is suitable for expressing PTHrP fragments or smaller proteins with simple structures that do not require complex post-translational modifications;

[0091] Yeast cells: used to perform some post-translational modifications of eukaryotic cells, such as glycosylation. They are relatively low-cost, but cannot fully simulate the complex modification process of mammalian cells. They are suitable for expressing PTHrP with moderate complexity, especially proteins that require a certain degree of post-translational modification.

[0092] Mammalian cells: used to provide post-translational modifications that are closest to the human environment, including glycosylation, phosphorylation, disulfide bond formation, etc., to ensure the correct folding and activity of PTHrP, but with high culture costs, slow growth rates, and relatively complex operations. They are suitable for expressing PTHrP with complex structures and requiring highly specific post-translational modifications;

[0093] Insect cells: Suitable for PTHrPs that are poorly expressed in E. coli but do not require complex modifications in mammalian cells;

[0094] S4. Culture and expression: The host cells were cultured using cell suspension culture technology to promote the expression of PTHrP. During the culture process, the aseptic operation specifications were strictly followed, and the cell density and growth status were regularly monitored. At the same time, fresh culture medium was replaced in a timely manner according to the cell growth and culture medium consumption. The culture process of cell suspension culture technology for different types of host cells is as follows:

[0095] Type 1: Suspension culture of Escherichia coli

[0096] Prepare the culture medium: Select LB medium as the culture medium for the growth of E. coli and perform sterilization;

[0097] Inoculation: Inoculate E. coli into the culture medium, making sure the inoculum volume is appropriate;

[0098] Shake flask culture: Place the inoculated culture medium in a shaker, set the appropriate temperature and speed, and perform suspension culture; the culture temperature is controlled at 32-37°C, and the pH value is controlled in the range of 7.0-7.5;

[0099] Observation and recording: Regularly observe the growth of E. coli and record the growth curve and colony morphology;

[0100] Collection and preservation: When E. coli grows to a suitable density, it is collected and preserved as needed;

[0101] Type 2: Suspension culture of yeast cells

[0102] Prepare the culture medium: Select YPD medium as the culture medium for yeast cell growth and perform sterile treatment;

[0103] Inoculation: Inoculate the yeast cells into the culture medium, making sure the inoculum volume is appropriate;

[0104] Shake flask or bioreactor culture: Place the inoculated culture medium in a shaker or bioreactor for suspension culture, and strictly control the temperature, pH value and ventilation volume; the culture temperature is controlled at 25-30°C, and the pH value range is controlled at 4.5-5.0;

[0105] Observation and recording: Regularly observe the growth and morphological changes of yeast cells and record relevant data;

[0106] Collection and utilization: Collect yeast cell supernatant or cell precipitate according to experimental requirements for subsequent experiments or production;

[0107] Type 3: Suspension culture of mammalian cells

[0108] Prepare the culture medium: Select serum-free medium as the culture medium for mammalian cell growth and perform sterilization;

[0109] Inoculation: Inoculate mammalian cells into culture medium at a density determined by cell type and experimental requirements;

[0110] Bioreactor culture: Use bioreactor for suspension culture, control parameters such as temperature, pH value and stirring speed to ensure that cells are evenly suspended and fully contact with the culture medium; the culture temperature is controlled at 36.5±0.5℃ and the pH value range is controlled at 7.4;

[0111] Observation and recording: Regularly observe the growth and morphological changes of cells and record relevant data;

[0112] Passaging and collection: When the cell density reaches a certain level, cell passage is performed and cell supernatant or cell pellet is collected as needed;

[0113] Type 4: Suspension culture of insect cells

[0114] Prepare the culture medium: Select SF900 medium as the culture medium for insect cell growth and perform sterile treatment;

[0115] Inoculation: Inoculate insect cells into the culture medium at a moderate density;

[0116] Shake flask or bioreactor culture: Place the inoculated culture medium in a shaker or bioreactor for suspension culture, and strictly control the temperature, pH value and ventilation volume; the culture temperature is controlled at 28°C and the pH value range is controlled at 6.0-6.4;

[0117] Observation and recording: Regularly observe the growth and morphological changes of insect cells and record relevant data;

[0118] Collection and utilization: Collect insect cell supernatant or cell precipitate according to experimental requirements for subsequent experiments or production;

[0119] The manipulation of PTHrP expression is as follows:

[0120] Gene transfection: Transfect the vector containing the PTHrP gene into the host cell so that it is integrated into the cell genome and expressed;

[0121] Induced expression: Use inducers, such as hormones, chemicals, etc., to stimulate host cells to express PTHrPS5. Separation and purification: Select chromatography columns and reagents with high resolution and stability, combine affinity chromatography and ion exchange chromatography, and perform multi-step purification to separate and purify PTHrP from cell culture. The operation process of affinity chromatography is as follows:

[0122] Ligand selection: Select a ligand with specific affinity to PTHrP, such as an antibody to PTHrP or its specific binding protein, to recognize and bind to PTHrP and separate it from other impurities;

[0123] Immobilized ligand: The selected ligand is immobilized on the insoluble matrix of the affinity chromatography column, such as agarose beads, by covalent bonding;

[0124] Sample processing: centrifuging and filtering the cell culture to remove cell debris and other impurities to obtain a crude extract containing PTHrP;

[0125] Affinity chromatography separation: The crude extract is passed through an affinity chromatography column, where PTHrP will bind to the ligand fixed on the matrix, while other impurities will flow out with the eluent;

[0126] Elution and collection: By changing the composition or conditions of the eluent, such as pH value, ionic strength, etc., PTHrP is dissociated from the ligand, and the eluent is collected, which contains high-purity PTHrP;

[0127] The operating procedure of ion exchange chromatography is as follows:

[0128] Selection of ion exchangers: Based on the charge properties of PTHrP, select cation or anion exchangers with charges opposite to those of PTHrP;

[0129] Sample loading: Load the preliminarily treated solution containing PTHrP onto the ion exchange chromatography column;

[0130] Elution and separation: PTHrP is gradually dissociated from the ion exchanger by gradually increasing the salt concentration of the eluent or changing the pH value. The dissociation rates of PTHrP and other impurities will be different under different conditions to achieve separation.

[0131] Collection and purification: Collect the eluate containing PTHrP and perform necessary subsequent treatments, such as concentration and desalting, to further improve purity and yield;

[0132] S6. Quality testing: The purity, activity and structure of PTHrP are identified through biological activity testing and mass spectrometry analysis.

[0133] The embodiments of the present invention are given for the purpose of illustration and description, and are not intended to be exhaustive or to limit the invention to the disclosed forms. Many modifications and variations will be apparent to those of ordinary skill in the art. The embodiments are selected and described in order to better illustrate the principles and practical applications of the present invention and to enable those of ordinary skill in the art to understand the present invention and thereby design various embodiments with various modifications suitable for specific uses.

Claims

1. A method for preparing a polypeptide capable of promoting bone cell growth, characterized in that: The following steps are involved: S1. Gene cloning: Obtain the gene sequence of PTHrP from the human genome or cDNA library, then amplify the PTHrP gene sequence by PCR, and sequence the amplified product to verify it. Compare the sequencing result with the original gene sequence to ensure that no errors or mutations are introduced; S2. Construction of expression vector: Considering the target host cell, the regulation mode of gene expression, the stability and capacity of the vector, plasmid, virus or yeast expression is selected as the expression vector, and the amplified PTHrP gene sequence is inserted into the expression vector; S3. Transformation of host cells: Select the most suitable host cell type according to the expression requirements of PTHrP, and transfer the constructed expression vector into the host cells to make the cells express PTHrP; S4. Culture and expression: host cells were cultured using cell suspension culture technology to promote the expression of PTHrP. During the culture process, aseptic operation specifications were strictly followed, and the cell density and growth status were regularly monitored. At the same time, fresh culture medium was replaced in a timely manner according to the cell growth and culture medium consumption; S5. Isolation and purification: Select chromatography columns and reagents with high resolution and stability, and use affinity chromatography and ion exchange chromatography in combination for multi-step purification to isolate and purify PTHrP from cell culture; S6. Quality testing: The purity, activity and structure of PTHrP are identified through biological activity testing and mass spectrometry analysis.

2. The method for preparing a polypeptide capable of promoting bone cell growth according to claim 1, characterized in that: In step S1, the specific steps of PCR amplification are as follows: Primer design: Based on the known PTHrP gene sequence, a pair of specific primers was designed; Template DNA preparation: Prepare template DNA according to the obtained gene sequence; PCR reaction system establishment: Set up the reaction system in a PCR tube, including template DNA, primers, dNTPs, PCR buffer and Taq enzyme; Thermal cycling: Place the PCR reaction system in a PCR instrument and perform thermal cycling; Product analysis: After the PCR reaction is completed, the PCR product is analyzed by agarose gel electrophoresis. The bands on the electrophoresis pattern are observed to determine whether the PCR amplification is successful and to preliminarily judge the quality and size of the product.

3. The method for preparing a polypeptide capable of promoting bone cell growth according to claim 2, characterized in that: The thermal cycle includes three steps of denaturation, annealing and extension, and these three steps are repeated 25 to 40 times. The specific operations of denaturation, annealing and extension are as follows: Denaturation: Under high temperature conditions of 94-98°C, the double-stranded template DNA is dissociated into single strands; Annealing: Lower the temperature to 50-65°C to allow the primer to bind to a specific site on the single strand of template DNA; Extension: Under high temperature conditions of 72°C, DNA polymerase extends along the primer to synthesize a new DNA chain.

4. The method for preparing a polypeptide capable of promoting bone cell growth according to claim 1, characterized in that: In step S2, when designing the expression vector, the PTHrP gene sequence is codon optimized according to the codon preference of the target host cell to improve the expression efficiency of the gene in the specific host cell and ensure that the vector contains elements that stabilize the mRNA structure.

5. The method for preparing a polypeptide capable of promoting bone cell growth according to claim 1, characterized in that: In step S3, the correspondence between the host cell type and the expression requirement of PTHrP is as follows: Escherichia coli: lacks the post-translational modification mechanism unique to eukaryotic cells and is suitable for expressing PTHrP fragments or smaller proteins with simple structures that do not require complex post-translational modifications; Yeast cells: used to perform some post-translational modifications of eukaryotic cells. They are relatively low-cost, but cannot fully simulate the complex modification process of mammalian cells. They are suitable for expressing PTHrP with moderate complexity, especially proteins that require a certain degree of post-translational modification. Mammalian cells: used to provide post-translational modifications that are closest to the human environment, ensuring the correct folding and activity of PTHrP, but with high culture costs, slow growth rates, and relatively complex operations. They are suitable for expressing PTHrP with complex structures and requiring highly specific post-translational modifications; Insect cells: Suitable for PTHrPs that are poorly expressed in E. coli but do not require the complex modifications of mammalian cells.

6. The method for preparing a polypeptide capable of promoting bone cell growth according to claim 1, characterized in that: In step S4, the culture process of the cell suspension culture technology for different types of host cells is as follows: Type 1: Suspension culture of Escherichia coli Prepare the culture medium: Select LB medium as the culture medium for the growth of E. coli and perform sterilization; Inoculation: Inoculate E. coli into the culture medium, making sure the inoculum volume is appropriate; Shake flask culture: Place the inoculated culture medium into a shaker, set the appropriate temperature and speed, and perform suspension culture; Observation and recording: Regularly observe the growth of E. coli and record the growth curve and colony morphology; Collection and preservation: When E. coli grows to a suitable density, it is collected and preserved as needed; Type 2: Suspension culture of yeast cells Prepare the culture medium: Select YPD medium as the culture medium for yeast cell growth and perform sterile treatment; Inoculation: Inoculate the yeast cells into the culture medium, making sure the inoculum volume is appropriate; Shake flask or bioreactor culture: Place the inoculated culture medium in a shaker or bioreactor for suspension culture, and strictly control the temperature, pH value and ventilation volume; Observation and recording: Regularly observe the growth and morphological changes of yeast cells and record relevant data; Collection and utilization: Collect yeast cell supernatant or cell pellet according to experimental requirements; Type 3: Suspension culture of mammalian cells Prepare the culture medium: Select serum-free medium as the culture medium for mammalian cell growth and perform sterilization; Inoculation: Inoculate mammalian cells into culture medium at a density determined by cell type and experimental requirements; Bioreactor culture: Use bioreactors for suspension culture, control parameters such as temperature, pH and stirring speed to ensure that cells are evenly suspended and fully exposed to the culture medium; Observation and recording: Regularly observe the growth and morphological changes of cells and record relevant data; Passaging and collection: When the cell density reaches a certain level, cell passage is performed and cell supernatant or cell pellet is collected as needed; Type 4: Suspension culture of insect cells Prepare the culture medium: Select SF900 medium as the culture medium for insect cell growth and perform sterile treatment; Inoculation: Inoculate insect cells into the culture medium at a moderate density; Shake flask or bioreactor culture: Place the inoculated culture medium in a shaker or bioreactor for suspension culture, and strictly control the temperature, pH value and ventilation volume; Observation and recording: Regularly observe the growth and morphological changes of insect cells and record relevant data; Collection and utilization: Collect insect cell supernatant or cell pellet according to experimental requirements.

7. The method for preparing a polypeptide capable of promoting bone cell growth according to claim 1, characterized in that: In step S4, the culture temperature is maintained within the optimal range for host cell growth according to the type of host cells, and the pH value of the culture medium is adjusted using a buffer. At the same time, it is ensured that there is sufficient oxygen and carbon dioxide concentration in the incubator to support the metabolic activities of the cells. The culture conditions for different types of host cells are as follows: Escherichia coli: The culture temperature is controlled at 32-37°C and the pH value is controlled at 7.0-7.5; Yeast cells: The culture temperature is controlled at 25-30°C and the pH value is controlled at 4.5-5.0; Mammalian cells: The culture temperature is controlled at 36.5±0.5℃ and the pH value is controlled at 7.4; Insect cells: The culture temperature was controlled at 28°C and the pH value was controlled in the range of 6.0 to 6.

4.

8. The method for preparing a polypeptide capable of promoting bone cell growth according to claim 1, characterized in that: In step S4, the operation of PTHrP expression is as follows: Gene transfection: Transfect the vector containing the PTHrP gene into the host cell so that it is integrated into the cell genome and expressed; Inducible expression: Use inducers to stimulate host cells to express PTHrP.

9. The method for preparing a polypeptide capable of promoting bone cell growth according to claim 1, characterized in that: In step S5, the operation process of affinity chromatography is as follows: Ligand selection: Select a ligand with specific affinity for PTHrP to recognize and bind to PTHrP and separate it from other impurities; Immobilization of ligand: Immobilization of the selected ligand on the insoluble matrix of the affinity chromatography column by covalent bonding; Sample processing: centrifuging and filtering the cell culture to remove cell debris and other impurities to obtain a crude extract containing PTHrP; Affinity chromatography separation: The crude extract is passed through an affinity chromatography column, where PTHrP will bind to the ligand fixed on the matrix, while other impurities will flow out with the eluent; Elution and collection: By changing the composition or conditions of the eluent, PTHrP is dissociated from the ligand, and the eluent is collected, which contains high-purity PTHrP.

10. The method for preparing a polypeptide capable of promoting bone cell growth according to claim 1, characterized in that: In step S5, the operation process of ion exchange chromatography is as follows: Selection of ion exchangers: Based on the charge properties of PTHrP, select cation or anion exchangers with charges opposite to those of PTHrP; Sample loading: Load the preliminarily treated solution containing PTHrP onto the ion exchange chromatography column; Elution and separation: PTHrP is gradually dissociated from the ion exchanger by gradually increasing the salt concentration of the eluent or changing the pH value; Collection and purification: Collect the eluate containing PTHrP and perform necessary subsequent treatment.